Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.56 |
| ▸ | CA12 | O43570 | 2/20 | 0.54 |
| ▸ | CA1 | P00915 | 2/20 | 0.54 |
| ▸ | CA7 | P43166 | 2/20 | 0.54 |
| ▸ | CA9 | Q16790 | 2/20 | 0.54 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.54 |
| ▸ | ACHE | P22303 | 1/20 | 0.54 |
| ▸ | APP | P05067 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 4/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29419589 | 1.00 | CA2 (0.56) | CA2CA12CA1CA7CA9 | |
| SCHEMBL1256865 | 0.97 | CA2 (0.54) | CA2CA12CA1CA7CA9 | |
| Ethyne SCHEMBL28045684 | 0.95 | CA2 (0.52) | CA2CA12CA1CA7CA9 | |
| Methyl Alcohol SCHEMBL28799088 | 0.95 | CA2 (0.52) | CA2CA12CA1CA7CA9 | |
| Formaldehyde SCHEMBL23581083 | 0.93 | CA2 (0.50) | CA2CA12CA1CA7CA9 | |
| SCHEMBL27601631 | 0.87 | SMN1; SMN2 (0.54) | CA2CA12CA1CA7CA9 | |
| SCHEMBL5607372 | 0.87 | CA2 (0.52) | CA2CA12CA1CA7CA9 | |
| SCHEMBL22360080 | 0.86 | TDP1 (0.45) | CA2CA12CA1CA7CA9 | |
| SCHEMBL1528898 | 0.84 | TDP1 (0.44) | CA2CA12CA1CA7CA9 | |
| SCHEMBL4908475 | 0.84 | TDP1 (0.44) | CA2CA12CA1CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1090 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116041153-B | Direct cross coupling method of aryl thioether and aryl bromine | 南京工业大学 | 2024-05-24 | — | — | CN | claimed |
| CN-117986614-A | Two-dimensional conductive metal organic framework material based on tetrathiafulvalene core and preparation method thereof | 天津理工大学 | 2024-05-07 | — | — | CN | claimed |
| CN-116253623-B | Direct cross-coupling method of aryl fluorine sulfate and aryl bromine | 南京工业大学 | 2024-04-05 | — | — | CN | claimed |
| CN-116554009-A | Electrophilic cross-coupling reaction method of aryl sulfone or heteroaryl sulfone and aryl bromide | 南京工业大学 | 2023-08-08 | — | — | CN | claimed |
| US-20230234918-A1 | AUTOMATED DIAZOMETHANE GENERATOR, REACTOR AND SOLID PHASE QUENCHER | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2023-07-27 | — | — | US | claimed |
| CN-116253623-A | Direct cross-coupling method of aryl fluorine sulfate and aryl bromine | 南京工业大学 | 2023-06-13 | — | — | CN | claimed |
| EP-4178942-A1 | AUTOMATED DIAZOMETHANE GENERATOR, REACTOR AND SOLID PHASE QUENCHER | Council Of Scientific & Industrial Research (IN) | 2023-05-17 | — | — | EP | claimed |
| CN-115449082-B | Metal organic coordination supermolecule sphere, preparation method and application thereof | 广州大学 | 2023-05-09 | — | — | CN | claimed |
| CN-116041153-A | Direct cross coupling method of aryl thioether and aryl bromine | 南京工业大学 | 2023-05-02 | — | — | CN | claimed |
| CN-115956066-A | Automatic diazomethane generator, reactor and solid phase quenching agent | 科学与工业研究委员会 | 2023-04-11 | — | — | CN | claimed |
| US-6776807-B2 | CONVEYING ELECTRODE WITH CONVEYOR, APPLYING ELECTROLYTE, WHICH IS DISCHARGED FROM DELIVERY OPENING OF FILLING UNIT UNDER PRESSURE, ONTO ELECTRODE CONVEYED TO POSITION UNDER OPENING, MAINTAINING THICKNESS OF ELECTROLYTE LAYER BY ADJUSTING ROLLER | SONY CORPORATION (JP) | 2004-08-17 | — | — | US | claimed |
| US-20030205201-A1 | Method of manufacturing a battery | MURATA MANUFACTURING CO., LTD. (JP) | 2003-11-06 | — | — | US | claimed |
| US-6632256-B1 | Method for manufacturing a non-aqueous-gel-electrolyte battery | SONY CORPORATION (JP) | 2003-10-14 | — | — | US | claimed |
| US-20020045094-A1 | Method of manufacturing a battery | TOHOKU MURATA MANUFACTURING CO.,LTD (JP) | 2002-04-18 | — | — | US | claimed |
| US-20020029465-A1 | Method of manufacturing a battery | SONY CORPORATION (JP) | 2002-03-14 | — | — | US | claimed |
| CN-1317842-A | Method for manufacturing battery | SONY CORP (JP) | 2001-10-17 | — | — | CN | claimed |
| CN-1316786-A | Manufacturing method of battery | SONY CORP (JP) | 2001-10-10 | — | — | CN | claimed |
| EP-1134831-A2 | Method of manufacturing a battery | SONY CORPORATION (JP) | 2001-09-19 | — | — | EP | claimed |
| EP-1134832-A2 | Method of manufacturing a battery | SONY CORPORATION (JP) | 2001-09-19 | — | — | EP | claimed |
| US-4605749-A | R)ACTING AN ORGANIC HALIDE WITH CARBON MONOXIDE USING A TRAN>ITION METAL CATALYST, A HYDROGEN DONOR, AND A BASE AT LOW PRESSURE | STATE OF ISRAEL, PRIME MINISTER'S OFFICE, ATOMIC ENERGY COMMISSION (IL) | 1986-08-12 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230234918-A1 | AUTOMATED DIAZOMETHANE GENERATOR, REACTOR AND SOLID PHASE QUENCHER | FTO, MNAT1, ALKBH2 | CA2 343/4885CA12 1365/4885CA1 471/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.